Table 2.
Activity of 30–56 (multi-substituted phenyl B-ring) against KB and KB-VIN
R | ED50 (µM)a | Selectivity | |||||
---|---|---|---|---|---|---|---|
2’ | 3’ | 4’ | 5’ | KB | KB-VIN | KB/KB-VIN | |
29 | Me | Me | 41.2 | 8.52 | 5 | ||
30 | Me | Me | 35.5 | 0.71 | 50 | ||
31 | Cl | Me | 39.0 | 2.15 | 18 | ||
32 | F | Me | 28.1 | 2.95 | 10 | ||
33 | Me | Me | Me | 8.2 | 4.37 | 2 | |
34 | Me | OMe | 20.9 | 2.62 | 8 | ||
35 | Me | OMe | 28.5 | 0.10 | 273 | ||
36 | OMe | OMe | 14.7 | 1.00 | 15 | ||
37 | F | OMe | 26.7 | 0.10 | 250 | ||
38 | Cl | OMe | 24.9 | 1.37 | 18 | ||
39 | Me | Me | OMe | 5.43 | 0.28 | 20 | |
40 | Me | OMe | Me | 36.6 | 7.58 | 5 | |
41 | OMe | OMe | OMe | 9.4 | 1.57 | 6 | |
42 | OMe | OMe | OMe | 46.7 | 5.6 | 8 | |
43 | Cl | OMe | OMe | 21.8 | 8.40 | 3 | |
44 | OH | OH | 10.0 | 5.41 | 2 | ||
45 | Me | Me | OH | 6.5 | 2.75 | 2 | |
46 | Me | OH | Me | 18.3 | 8.90 | 2 | |
47 | Me | Me | 3.1 | 0.85 | 4 | ||
48 | Me | Me | 14.5 | 3.41 | 4 | ||
49 | Me | Me | 45.5 | 0.45 | 100 | ||
50 | OMe | OMe | 35.2 | 4.02 | 9 | ||
51 | OMe | OMe | 8.8 | 2.51 | 4 | ||
52 | OMe | OMe | 45.2 | 3.27 | 14 | ||
53 | OEt | OEt | 44.6 | 31.69 | 1.4 | ||
54 | F | Me | 47.3 | 3.24 | 15 | ||
55 | Me | F | 40.5 | 1.62 | 24 |
Cytotoxicity as ED50 values for each cell line, the concentration of compound that caused 50% reduction in absorbance at 562 nm relative to untreated cells using the sulforhodamine B assay.